Ruth Swann
Overview
Explore the profile of Ruth Swann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1032
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akter N, Lyratzopoulos G, Swann R, Rubin G, McPhail S, Rafiq M, et al.
BMJ Qual Saf
. 2024 Oct;
PMID: 39443159
Introduction: Use of investigations can help support the diagnostic process of patients with cancer in primary care, but the size of variation between patient group and between practices is unclear....
2.
Merriel S, Merriel S, Akter N, Zakkak N, Swann R, McPhail S, et al.
Br J Gen Pract
. 2024 Oct;
PMID: 39401928
Background: Prostate-specific antigen (PSA) is used in primary care for prostate cancer detection, either for symptomatic assessment or asymptomatic testing following an informed decision. Aim: To estimate the proportion of...
3.
Swann R, Lyratzopoulos G, Rubin G, Elliss-Brookes L, McPhail S
Cancer Epidemiol
. 2024 Aug;
92:102607.
PMID: 39167911
Background: Diagnosis of cancer soon after emergency care use is associated with adverse prognosis. We aimed to more precisely explore different definitions of emergency diagnosis. Methods: For 43,383 patients in...
4.
Barclay M, McPhail S, Johnson S, Swann R, Lyratzopoulos G
Lancet Oncol
. 2024 May;
25(6):e232.
PMID: 38821093
No abstract available.
5.
McPhail S, Barclay M, Swann R, Johnson S, Alvi R, Barisic A, et al.
Lancet Oncol
. 2024 Feb;
25(3):352-365.
PMID: 38423049
Background: There is little evidence on variation in radiotherapy use in different countries, although it is a key treatment modality for some patients with cancer. Here we aimed to examine...
6.
McPhail S, Barclay M, Johnson S, Swann R, Alvi R, Barisic A, et al.
Lancet Oncol
. 2024 Feb;
25(3):338-351.
PMID: 38423048
Background: There are few data on international variation in chemotherapy use, despite it being a key treatment type for some patients with cancer. Here, we aimed to examine the presence...
7.
Cranfield B, Abel G, Swann R, Moore S, McPhail S, Rubin G, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509248
Background: Blood tests can support the diagnostic process in primary care. Understanding how symptomatic presentations are associated with blood test use in patients subsequently diagnosed with cancer can help to...
8.
Swann R, McPhail S, Abel G, Witt J, Wills L, Hiom S, et al.
Br J Gen Pract
. 2023 May;
73(733):e566-e574.
PMID: 37253630
Background: Timely diagnosis of cancer in patients who present with symptoms in primary care is a quality-improvement priority. Aim: To examine possible changes to aspects of the diagnostic process, and...
9.
Cranfield B, Koo M, Abel G, Swann R, McPhail S, Rubin G, et al.
Br J Gen Pract
. 2022 Oct;
73(727):e95-e103.
PMID: 36253112
Background: Blood tests can support the diagnostic process in patients with cancer but how often they are used is unclear. Aim: To explore use of common blood tests before cancer...
10.
McPhail S, Swann R, Johnson S, Barclay M, Abd Elkader H, Alvi R, et al.
Lancet Oncol
. 2022 Apr;
23(5):587-600.
PMID: 35397210
Background: Greater understanding of international cancer survival differences is needed. We aimed to identify predictors and consequences of cancer diagnosis through emergency presentation in different international jurisdictions in six high-income...